IO Biotech, Inc.
IOBTDelisted Jun 8, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001865494
IO Biotech, Inc. was delisted on Jun 8, 2026; its insiders filed their last Form 4 on Jun 6, 2025; 12 institutions reported holding it in 13F filings for Q1 2026, worth $199.0K in total; no superinvestor held it.
Q1 2026 vs. Q4 2025
How the institutions holding IO Biotech, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Q1 2026 | Change |
|---|---|---|---|
| Holders | 22 | 12 | −10 |
| Shares | 7.85M | 3.39M | −4.46M (−56.8%) |
| Value | $4.78M | $199.0K | −$4.58M (−95.8%) |
New holders (2)
Institutions that held IO Biotech, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Gsa Capital Partners LLP | 348,352 | $20.0K | 0.00% |
| Jane Street Group, LLC | 57,974 | $3.40K | 0.00% |
Sold out (12)
Institutions that held IO Biotech, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Novo Holdings A/S | 2,512,453 | $1.53M |
| Bank of America Corp | 799,953 | $486.4K |
| Dauntless Investment Group, LLC | 451,641 | $275.0K |
| Renaissance Technologies LLC | 207,601 | $126.4K |
| Bridgeway Capital Management, LLC | 75,000 | $45.7K |
| Two Sigma Securities, LLC | 44,757 | $27.3K |
| Hilton Capital Management, LLC | 25,510 | $15.5K |
| ADAR1 Capital Management, LLC | 24,964 | $15.2K |
| PKS Advisory Services, LLC | 20,000 | $12.2K |
| Virtu Financial LLC | 19,078 | $12.0K |
| Scientech Research LLC | 11,255 | $6.85K |
| SBI Securities Co., Ltd. | 122 | $74 |